Floatz logo

Zoledronate

Thalassemia Majors (Beta-Thalassemia Major)

Hamad Medical CorporationSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

32 Active assets in the Thalassemia Majors (Beta-Thalassemia Major) cohort.

Asset / SponsorPhaseRating
Deferasirox
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
TACROLIMUS
M.D. Anderson Cancer Center
Phase 4BBB
DESFERRIOXAMINE B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB

View all 50 →

Same molecule, other indications

Zoledronate is also rated in:

metastatic carcinoma in the boneDormant
BBB
Indicative ·
79 / 100
View asset →
osteoporosisDormant
BBB
Indicative ·
76 / 100
View asset →
breast carcinomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →